share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Apr 1 20:08

Gainers

  • Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. The market value of their outstanding shares is at $12.3 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Sunshine Biopharma (NASDAQ:SBFM) shares rose 46.11% to $0.09. The company's market cap stands at $8.7 million.
  • Qilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 44.94% to $1.0. The market value of their outstanding shares is at $35.7 million.
  • Xilio Therapeutics (NASDAQ:XLO) stock moved upwards by 27.77% to $1.38. The market value of their outstanding shares is at $37.9 million.
  • Innate Pharma (NASDAQ:IPHA) shares moved upwards by 18.05% to $3.4. The company's market cap stands at $274.8 million.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) stock rose 14.76% to $0.43.

Losers

  • ENDRA Life Sciences (NASDAQ:NDRA) shares decreased by 29.3% to $0.41 during Monday's pre-market session. The market value of their outstanding shares is at $4.5 million. The company's, Q4 earnings came out 2 days ago.
  • SINTX Techs (NASDAQ:SINT) shares declined by 21.42% to $0.04. As per the news, the Q4 earnings report came out 3 days ago.
  • Fractyl Health (NASDAQ:GUTS) shares declined by 20.95% to $5.85. The market value of their outstanding shares is at $278.5 million.
  • Vivos Therapeutics (NASDAQ:VVOS) shares declined by 17.19% to $4.0. The company's market cap stands at $5.3 million. The company's, Q4 earnings came out 2 days ago.
  • Avalo Therapeutics (NASDAQ:AVTX) stock fell 16.55% to $18.15. The market value of their outstanding shares is at $14.5 million.
  • Applied Therapeutics (NASDAQ:APLT) stock declined by 14.56% to $5.81. The company's market cap stands at $615.2 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment